Day: June 5, 2023

Prenetics Announces First Quarter 2023 Financial Results

HONG KONG, June 05, 2023 (GLOBE NEWSWIRE) — Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading genomics and precision oncology company, today announced financial results for the first quarter ended March 31, 2023, along with recent business updates. First Quarter 2023 Financial Highlights Revenue of US$17.7 million Adjusted EBITDA of US$(5.7) million Cash and other short-term assets1 of US$224.1 million as of March 31, 2023 _______________1 Represents current assets, including cash and cash equivalents and short-term deposits totaling US$186.2 million, financial assets at fair value through profit or loss of US$17.5 million, and trade receivables of US$5.7 million, amongst other accounting line items under current assets. Recent Business Updates Joel Neoh, highly successful serial entrepreneur,...

Continue reading

Diversified Royalty Corp. Announces Completion of BMO Acquisition of Air MILES Reward Program Business and June 2023 Cash Dividend

VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) — Diversified Royalty Corp. (TSX: DIV and DIV.DB.A) (the “Corporation” or “DIV”) is pleased to announce that on June 1, 2023 the Bank of Montreal (“BMO”) issued a news release (the “BMO News Release”) confirming BMO completed its previously announced acquisition of the AIR MILES Reward Program business from LoyaltyOne, Co. (the “AIR MILES Acquisition”). In addition, DIV is also pleased to announce that its board of directors has approved a cash dividend of $0.02 per common share for the period of June 1, 2023 to June 30, 2023, which is equal to $0.24 per common share on an annualized basis. The dividend will be paid on June 30, 2023 to shareholders of record as of the close of business on June 15, 2023. BMO Completes Acquisition of Air Miles Reward Program Business According...

Continue reading

Alpha Lithium Responds to Tecpetrol Announcement of Intention to Make Below Market Tender Offer

VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) — Alpha Lithium Corporation (NEO: ALLI) (OTC: APHLF) (German WKN: A3CUW1) (“Alpha Lithium” or the “Company”) today responded to the June 2, 2023 announcement by Tecpetrol Investments S.L. (“Tecpetrol”) of its intention to make an unsolicited takeover bid offer to acquire all of Alpha Lithium’s issued and outstanding shares at $1.24 per share (the “Offer”). Tecpetrol’s Offer price represents a discount to the current 10-day weighted average price of $1.27 per share and a premium of only 7.8% to the share price immediately prior to Tecpetrol’s May 22, 2023 announcement. Alpha Lithium shareholders are not required to take any action in response to the Tecpetrol announcement at this time, as a potential Offer has only been announced, and not formally made. The Alpha Lithium...

Continue reading

Atlas One Capital Corporation Announces Termination of Proposed Qualifying Transaction

Toronto, Ontario, June 05, 2023 (GLOBE NEWSWIRE) — Atlas One Capital Corporation (TSXV: ACAP.P) (the “Corporation“) or “Atlas One“), a capital pool company listed on the TSX Venture Exchange (“TSXV“), announces the termination of its proposed arm’s length qualifying transaction with Zodiac Gold Inc. (“Zodiac Gold“), previously announced on November 8, 2022, which was intended to constitute the Corporation’s “Qualifying Transaction” as such term is defined in TSXV Policy 2.4. The Corporation will continue to pursue and evaluate other businesses and assets with a view to completing a Qualifying Transaction and will make further announcements with respect to these efforts as soon as practically possible and, in the interim, will apply to the TSXV to reinstate trading of the...

Continue reading

EnviroGold Global Closes $2.15M Financing

TORONTO, June 05, 2023 (GLOBE NEWSWIRE) — EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) (“EnviroGold Global” or the “Company”), a Clean Technology Company accelerating the world’s transition to a circular-resource economy, is pleased to announce that further to the news release dated May 29, 2023, it has closed a non-brokered private placement of unsecured convertible notes (the “Notes”) with two investor groups to raise gross proceeds of $2.15M (the “Financing”). The Notes will mature twenty-four (24) months from the date of issuance (the “Maturity Date”) and bear interest at the rate of 8.0% per annum, calculated as simple interest accrued monthly in arrears. Pursuant to the terms of the Notes, the subscribers may at any time prior to the Maturity Date convert the principal amounts of the Notes into common shares...

Continue reading

Ocugen, Inc. Announces Business Advisory Board

MALVERN, Pa., June 05, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced that the Company has established a Business Advisory Board to assist in driving public/private partnerships with governments around the world; pursuing business collaborations, partnerships, and licensing opportunities; creating awareness of the Company’s differentiated capabilities; and promoting access to the Company’s therapies around the world. “I am delighted to welcome this notable group of advisors to Ocugen,” said Dr. Shankar Musunuri, Chairman, CEO and Co-founder of Ocugen. “At this stage in the Company’s growth, it is critical to foster collaborations—among industry and...

Continue reading

Allakos Announces Upcoming Presentation on Lirentelimab and AK006 Mast Cell Inhibition at the European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress 2023

SAN CARLOS, Calif., June 05, 2023 (GLOBE NEWSWIRE) — Allakos Inc. (Nasdaq: ALLK), a clinical-stage biotechnology company developing therapeutics which target immunomodulatory receptors present on immune effector cells involved in allergy, inflammatory and proliferative diseases, today announced an oral presentation at the upcoming European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress 2023.   EAACI is being held June 9-11, 2023 in Hamburg, Germany. Oral Presentation Details: Title: Global Protein Interactions of Siglec-6 and Siglec-8 Reveal Distinct Differences in Regulating Mast Cell FunctionSession: Targeted Approach in AllergyAbstract No: 000406Presenting Author: Wouter Korver PhDDate and Time: Saturday, June 10, 2023, 8:30-10:00 CET About Allakos Allakos is a clinical stage biotechnology company developing...

Continue reading

Harju Elekter Group signed a lease agreement with Prysmian Group Baltics AS

AS Harju Elekter Group and Prysmian Group Baltics AS signed a lease agreement on 5 June 2023 until 2030. With the extended lease agreement, the real estate department of Harju Elekter Group leases to Prysmian Group Baltics more than 20,000 m² of production, storage and office space and nearly 40,000 m² of external storage territory. The contract also agreed on a large-scale renovation and reconstruction of the premises, the investment cost of which is up to 3 million euros. Prysmian Group is a major global company at the forefront of innovative cable technology and whose shares are listed on the Milan Stock Exchange. Each year, the Group manufactures thousands of kilometers of underground and submarine cables and systems for power transmission and distribution, as well as medium and low voltage cables for the construction and infrastructure...

Continue reading

Results of Admiral Markets AS bond buyback offer

On June 2, 2023, at 4:00 p.m., the buyback offer for Tier 2 bonds issued by Admiral Markets AS (ISIN EE3300111251, nominal value 100 euros per bond, due December 28, 2027, hereinafter the bond) ended. During the period of submission of buyback orders, orders for the buyback of 4,733 bonds were received from 60 investors. The price of one bond was 104.53 euros, of which 100 euros is the nominal price of the bond, 1 euro is the bonus and 3.53 euros is the interest. As a result of the buyback distribution, each investor can sell back all the bonds specified in the buyback order. All investors were able to offer their bonds to Admiral Markets AS for repurchase on equal terms. The bond and money transfer date, or settlement day, is June 7, 2023. For more information, please contact: Kaia Gil Communication manager of Admiral Markets ASkaia.gil@admiralmarkets.com +372...

Continue reading

Form 8.3 – [Emis Group Plc – 02 06 2023] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients) (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree EMIS GROUP PLC (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A (e)   Date position held/dealing...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.